Anhui Ends Unnecessary Infusions For 53 Common Diseases
This article was originally published in PharmAsia News
Anhui’s provincial Health and Family Planning Commission recently issued a “Notice on Strengthening Management of Intravenous Infusion in Medical Institutes”, providing a list of 53 common diseases that do not require intravenous infusions.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.